BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 15586785)

  • 1. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.
    Mamelak M; Black J; Montplaisir J; Ristanovic R
    Sleep; 2004 Nov; 27(7):1327-34. PubMed ID: 15586785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J; Houghton WC
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    J Clin Sleep Med; 2010 Dec; 6(6):596-602. PubMed ID: 21206549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.
    Sleep; 2003 Feb; 26(1):31-5. PubMed ID: 12627729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP; Kotagal S
    Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group
    J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy.
    Weaver TE; Cuellar N
    Sleep; 2006 Sep; 29(9):1189-94. PubMed ID: 17040006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate.
    Murali H; Kotagal S
    Sleep; 2006 Aug; 29(8):1025-9. PubMed ID: 16944670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS; Guilleminault C
    Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy.
    Roth T; Dauvilliers Y; Guinta D; Alvarez-Horine S; Dynin E; Black J
    J Sleep Res; 2017 Aug; 26(4):407-414. PubMed ID: 27807903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium oxybate for excessive daytime sleepiness in narcolepsy-cataplexy.
    Arnulf I; Mignot E
    Sleep; 2004 Nov; 27(7):1242-3. PubMed ID: 15586777
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
    Ondo WG; Perkins T; Swick T; Hull KL; Jimenez JE; Garris TS; Pardi D
    Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of acute administration of sodium oxybate on nocturnal sleep polysomnography and on multiple sleep latency test in narcolepsy with cataplexy.
    Plazzi G; Pizza F; Vandi S; Aricò D; Bruni O; Dauvilliers Y; Ferri R
    Sleep Med; 2014 Sep; 15(9):1046-54. PubMed ID: 25087195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of sodium oxybate as a treatment option for narcolepsy.
    Abad VC
    Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of sodium oxybate on core body and skin temperature regulation in narcolepsy.
    van der Heide A; Donjacour CE; Pijl H; Reijntjes RH; Overeem S; Lammers GJ; Van Someren EJ; Fronczek R
    J Sleep Res; 2015 Oct; 24(5):566-75. PubMed ID: 25913575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria for gauging response to sodium oxybate for narcolepsy.
    Steffen AD; Lai C; Weaver TE
    J Sleep Res; 2018 Aug; 27(4):e12628. PubMed ID: 29205601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.